Navdeep Dehar | Oncology | Excellence in Research

Dr.Navdeep Dehar | Oncology | Excellence in Research

Medical Oncologist Queens University Canada

Navdeep Dehar MBBS MD MBT FRCPC is an Assistant Professor in the Department of Oncology at Queen’s University and a Clinician Investigator & Medical Oncologist at the Cancer Centre of Southeastern Ontario. Additionally, he serves as a Precision Medicine Research Fellow at the Canadian Cancer Trials Group. With extensive training and experience in oncology, pharmacology, and biomedical technology, Dr. Dehar has made significant contributions to cancer research and clinical practice.

Profile

Scopus

Education

🎓 Education:

  • Subspecialty Training in Medical Oncology (2021-2023) – Queen’s University, Kingston, ON
  • Residency in Internal Medicine (2018-2021) – Cumming School of Medicine, University of Calgary, Alberta
  • Master of Biomedical Technology (MBT) (2012-2013) – University of Calgary, Alberta
  • Residency in Pharmacology – Doctor of Medicine (MD) (2005-2008) – Baba Farid University of Health Sciences, India
  • Bachelor of Medicine and Bachelor of Surgery (MBBS) (1998-2002) – Dayanand Medical College and Hospital, Baba Farid University of Health Sciences, India

Experience

💼 Experience:

  • Clinician Investigator & Staff Medical Oncologist (Locum) (July 2023 – present) – Cancer Centre of Southeastern Ontario, Kingston, ON
  • Assistant Professor of Medical Oncology (July 2023 – present) – Department of Medical Oncology, Queen’s University, Kingston, ON
  • Precision Medicine Research Fellow (October 2023 to September 2024) – Canadian Clinical Trials Group (CCTG), Kingston, ON
  • Medical Oncology Resident (2021-2023) – Queen’s University, Kingston, ON
  • Internal Medicine Resident (2018-2021) – University of Calgary, AB
  • Clinical Research Consultant (2013-2018) – GNR Biomedical Inc.

Research Interests

🔬 Research Interests:

  • Gastrointestinal Cancers
  • Neuroendocrine Tumors
  • Breast Cancer
  • Precision Oncology
  • Artificial Intelligence/Machine Learning in Oncology
  • Quality Improvement in Clinical Trials
  • Cancer Therapeutics with a Focus on Pharmacogenomics
  • Patient and Physician Education Initiatives
  • Global Oncology with a Focus on Quality Improvement

Awards

🏆 Awards:

  • Scholarship for Training in Lung Cancer (2023) – Canadian Lung Cancer Conference, Vancouver
  • Award of Appreciation for Extraordinary Contribution to Resident Redeployment Initiative during COVID Pandemic (2022) – Queen’s University, Kingston
  • Dr. Chirag Shah International Medical Graduate Award Recipient (2018) – Alberta International Medical Graduate Program, University of Calgary
  • Young Scientist Award (2008) – Sant Longowal Institute of Science and Technology, India

Publications

📚 Publications:

  • Dehar N, Gupta A, Singh G. “Comparative Study of the Efficacy and Safety of Ketorolac Tromethamine 0.5% Ophthalmic Solution and Diclofenac Sodium 0.1% Ophthalmic Solution in Patients of Acute Seasonal Allergic Conjunctivitis.” Int J Appl Basic Med Res. 2012 Jan-Jun; 2(1): 25–30. doi:10.4103/2229-516X.96799
  • Miriam Mutebi, Navdeep Dehar, Leticia M. Nogueira, Kewei Shi, K. Robin Yabroff,
    and Bishal Gyawali. Cancer Groundshot: Building a Robust Cancer Control Platform in
    Addition To Launching the Cancer Moonshot. American Society of Clinical Oncology
    Educational Book 2022:42, 1-16

Jing Yu – Pharmacology- Best Researcher Award

Jing Yu - Pharmacology- Best Researcher Award

Shanghai Jiao Tong University - China

Professional Profiles

Early Academic Pursuits

Jing Yu's academic journey began with a solid foundation in pharmaceutical studies. She earned her Bachelor's degree from Shenyang Pharmaceutical University/Jilin University, China, spanning from 1996 to 2000. Building on this, she pursued a Master's degree at Shenyang Pharmaceutical University from 2000 to 2002. These early academic pursuits laid the groundwork for Jing Yu's future endeavors in the field of life sciences.

Professional Endeavors

Professor Assistant at Shanghai Jiao Tong University (2002-2004)

Jing Yu's foray into academia commenced with her role as a Professor Assistant at Shanghai Jiao Tong University from September 2002 to December 2004. During this period, she honed her skills in teaching and research, gaining valuable experience that would shape her academic career.

Ph.D. at University of Basel, Switzerland (2005-2008)

In pursuit of advanced academic and research opportunities, Jing Yu pursued her Ph.D. at the University of Basel in Switzerland from January 2005 to May 2008. This international experience broadened her perspectives and allowed her to engage with a diverse scientific community.

Senior Scientist at University of Geneva, Switzerland (2008-2010)

Jing Yu continued her academic journey as a Senior Scientist at the University of Geneva from June 2008 to August 2010. This role provided her with an opportunity to contribute to cutting-edge research and collaborate with experts in the field.

Assistant and Associate Professor at Shanghai Jiao Tong University (2010-present)

Returning to her alma mater, Jing Yu took on the role of Assistant Professor at Shanghai Jiao Tong University in September 2010. Her dedication and contributions propelled her to the position of Associate Professor in December 2013, solidifying her standing as a prominent figure in the School of Life Sciences and Biotechnology.

Contributions and Research Focus

Jing Yu's research focus revolves around the intricate world of cancer diseases. Specifically, she dedicates her efforts to discovering mediators for therapeutic targets in cancer and studying the mechanisms underlying these diseases. Additionally, her work extends to the critical domain of drug targeting delivery, aiming to enhance the effectiveness of cancer treatments.

Accolades and Recognition

Jing Yu's contributions to the field of cancer research and drug targeting have likely garnered accolades and recognition within the academic community. Awards and honors may have been bestowed upon her, acknowledging the impact of her work on advancing our understanding of cancer therapeutics.

Impact and Influence

Jing Yu's impact is felt through her significant contributions to cancer research. By delving into the complexities of therapeutic targets and drug delivery mechanisms, she has likely influenced the scientific community's approach to cancer treatment. Her work may have implications for developing more targeted and efficient therapies, ultimately benefiting patients.

Legacy and Future Contributions

Jing Yu's legacy is marked by her journey from early academic pursuits to becoming an Associate Professor at Shanghai Jiao Tong University. Her future contributions are anticipated to further shape the landscape of cancer research, leaving a lasting imprint on the understanding and treatment of cancer diseases.

Future Contributions

Looking ahead, Jing Yu envisions expanding her research portfolio to address emerging challenges in cancer therapeutics. Her commitment to advancing drug targeting delivery methods and understanding the intricacies of cancer diseases is expected to lead to innovative solutions with broader applications in the field.

Notable Publications